Omotunde O. Osunsanmi

FDA investigator

Appears on 13 documents from 2003 to 2020, most often at sites in United Kingdom. Most often cites control of microbiological contamination (21 CFR 211.113).

13
Documents on file
11.0
Observations per 483
2003
First seen
2020
Most recent

What they cite most

From 123 observations

Activity by year

2003: 2, 2004: 1, 2007: 1, 2010: 1, 2014: 1, 2017: 1, 2018: 2, 2019: 3, 2020: 1

Where

United Kingdom 5 · California 3 · France 1 · Germany 1 · Netherlands 1 · Pennsylvania 1

Is Omotunde O. Osunsanmi coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

13 documents, newest first
FirmOpen
483 BioConnection B.V.Mar 4, 2020 · Oss, Netherlands
483 Dendreon Pharmaceuticals LLCNov 8, 2019 · Seal Beach, California
483 Grifols Biologicals LLCSep 12, 2019 · City of Industry, California
483 PCI San Diego, Inc.Feb 7, 2019 · San Diego, California
483 MedImmune UK LimitedJun 8, 2018 · Liverpool, United Kingdom
483 Sanofi Winthrop IndustrieMay 25, 2018 · Le Trait, France
EIR Merck Sharp & Dohme Corp.Apr 28, 2017 · West Point, Pennsylvania

About this profile

What does Omotunde O. Osunsanmi inspect?

Omotunde O. Osunsanmi appears on 13 documents on file covering 10 sites, most often in United Kingdom.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.42.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Omotunde O. Osunsanmi is dated Mar 4, 2020.